During the past decade, Collaborative Neuroscience Network, LLC conducted 184 clinical trials. In the 10-year time frame, 184 clinical trials started and 126 clinical trials were completed, i.e. on average, 68.5% percent of trials that started reached the finish line to date. In the past 5 years, 68 clinical trials started and 74 clinical trials were completed. i.e. 108.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Collaborative Neuroscience Network, LLC" #1 sponsor was "Sunovion" with 33 trials, followed by "Pfizer" with 22 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 15 trials sponsored, "Hoffmann-La Roche" with 9 trials sponsored and "Indivior Inc." with 9 trials sponsored. Other sponsors include 192 different institutions and companies that sponsored additional 114 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Collaborative Neuroscience Network, LLC" #1 collaborator was "H. Lundbeck A/S" with 6 trials as a collaborator, "Cognitive Research Corporation" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "BrainCells Inc." with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Collaborative Neuroscience Network, LLC" are "Schizophrenia" (74 trials), "Alzheimer's Disease" (20 trials), "Major Depressive Disorder" (19 trials), "Depressive Disorder, Major" (14 trials) and "Parkinson's Disease" (10 trials). Many other conditions were trialed in "Collaborative Neuroscience Network, LLC" in a lesser frequency.

Most popular intervention types in "Collaborative Neuroscience Network, LLC" are "Drug" (269 trials), "Other" (21 trials), "Biological" (13 trials), "Combination Product" (3 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (142 trials), "Lurasidone" (9 trials), "placebo" (9 trials), "Risperidone" (7 trials) and "Brexpiprazole" (5 trials). Other intervention names were less common.

The vast majority of trials in "Collaborative Neuroscience Network, LLC" are 281 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Collaborative Neuroscience Network, LLC". undefined are not yet recruiting, 13 are recruiting, 13 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 222 completed trials in Collaborative Neuroscience Network, LLC, 1 suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Collaborative Neuroscience Network, LLC, 60 "Phase 1" clinical trials were conducted, 106 "Phase 2" clinical trials and 114 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 4 trials that are defined as “Not Applicable".

Collaborative Neuroscience Network, LLC has several departments that took part in Clinical trials: "Collaborative Neuroscience Network Inc.,12772 Valley View Street,Suite 3" - 2 trials